CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
COMPACT aims to improve the delivery of biopharmaceuticals through innovative non-invasive administration routes. The project focuses on understanding transport pathways across biological barriers and developing formulations that enhance the uptake of various biopharmaceuticals, including RNA-based therapies.
Most biopharmaceuticals (BP) currently on the market are recombinant proteins which are parenterally administered.
These would benefit from more patient-friendly routes of administration.
Moreover, new classes of BP (e.g. siRNA, miRNA, DARPins) with specificity for intracellular targets hold promise but await the advent of efficient delivery systems before their potential can be realised into therapeutic products.
Solving the bottleneck of BP delivery is one of the main incentives of the pharmac…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Utrecht
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Denmark, Kobenhavn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Cardiff
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
